Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
BDX

BDX - Becton Dickinson and Co Stock Price, Fair Value and News

$201.87-1.53 (-0.75%)
Market Closed

49/100

BDX

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

49/100

BDX

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$185.04

Target 3M

$197.55

Target 6M

$193.31

BDX Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

BDX Price Action

Last 7 days

-2.1%

Last 30 days

3.4%

Last 90 days

12.5%

Trailing 12 Months

-18.9%

BDX RSI Chart

BDX Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

BDX Valuation

Market Cap

57.6B

Price/Earnings (Trailing)

34.34

Price/Sales (Trailing)

2.64

EV/EBITDA

15.05

Price/Free Cashflow

21.58

BDX Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$185.04

Target 3M

$197.55

Target 6M

$193.31

BDX Fundamentals

BDX Revenue

Revenue (TTM)

21.8B

Rev. Growth (Yr)

8.35%

Rev. Growth (Qtr)

6.93%

BDX Earnings

Earnings (TTM)

1.7B

Earnings Growth (Yr)

23.25%

Earnings Growth (Qtr)

-14.11%

BDX Profitability

EBT Margin

8.61%

Return on Equity

6.61%

Return on Assets

3.03%

Free Cashflow Yield

4.63%

BDX Investor Care

Dividend Yield

2.06%

Dividend/Share (TTM)

4.16

Buy Backs (1Y)

1.28%

Diluted EPS (TTM)

5.83

BDX Alerts

  • 1 major insider sales recently.

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202520.9B21.4B21.8B0
202419.7B19.8B20.2B20.6B
202318.8B19.0B19.4B19.5B
202218.7B18.7B18.9B18.7B
202118.9B19.6B19.4B18.8B
202017.4B16.9B17.1B18.2B
201917.0B17.1B17.3B17.4B
201813.5B14.7B16.0B17.1B
201712.3B12.2B12.1B12.3B
201612.2B12.3B12.5B12.4B
20158.5B9.4B10.3B11.2B
20148.2B8.3B8.4B8.5B
20137.8B7.9B8.1B8.2B
20127.6B7.7B7.7B7.8B
20117.2B7.3B7.6B7.6B
20100007.1B
Get all data in R, Python etc through our Historical Stock Data APIs

About Becton Dickinson and Co

BDX
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.
 CEO
 WEBSITEbd.com
 SECTORHealthcare
 INDUSTRYMedical Instruments & Supplies
 EMPLOYEES65535

Becton Dickinson and Co Frequently Asked Questions

BDX is the stock ticker symbol of Becton Dickinson and Co. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Becton Dickinson and Co is 57.62 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check BDX's fair value in chart for subscribers.

The fair value guage provides a quick view whether BDX is over valued or under valued. Whether Becton Dickinson and Co is cheap or expensive depends on the assumptions which impact Becton Dickinson and Co's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for BDX.

As of Wed Jan 28 2026, BDX's PE ratio (Price to Earnings) is 34.34 and Price to Sales (PS) ratio is 2.64. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. BDX PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Becton Dickinson and Co has provided 0.036 (multiply by 100 for percentage) rate of return.